Showing results (931-940 of 2,915) with videos related to

Sort By:
Pageof 292
Cancer Gene Therapy|April 30, 2003
Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killingRainer Wiewrodt, Kunjlata Amin, Michael Kiefer, et al.
Cancer Gene Therapy|April 30, 2003
Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colonHakan Akbulut, Lixin Zhang, Yucheng Tang, et al.
Cancer Gene Therapy|July 23, 2003
Sustained P450 expression and prodrug activation in bolus cyclophosphamide-treated cultured tumor cells. Impact of prodrug schedule on P450 gene-directed enzyme prodrug therapyPamela S Schwartz, Chong-Sheng Chen, David J Waxman
Cancer Gene Therapy|July 23, 2003
Dendritic cells infected with a vaccinia virus interleukin-2 vector secrete high levels of IL-2 and can become efficient antigen presenting cells that secrete high levels of the immunostimulatory cytokine IL-12Sutapa Mukherjee, John W Upham, Ian Ramshaw, et al.
Cancer Gene Therapy|December 19, 2003
Combined suicide gene therapy for pancreatic peritoneal carcinomatosis using BGTC liposomesAmor Hajri, Séverine Wack, Pierre Lehn, et al.
Cancer Gene Therapy|December 27, 2003
A nonviral carrier for targeted gene delivery to tumor cellsJacoba van Zanten, Berber Doornbos-Van der Meer, Sandrine Audouy, et al.
Cancer Gene Therapy|January 9, 2004
Complete tumor prevention by engineered tumor cell vaccines employing nonviral vectorsInés Moret-Tatay, Joaquín Díaz, Francisco M Marco, et al.
Cancer Gene Therapy|January 9, 2004
Non-small lung cancer cells are prime targets for p53 gene transfer mediated by a recombinant adeno-associated virus type-2 vectorUlrich-Peter Rohr, Marc-Andre Wulf, Susanne Stahn, et al.
Cancer Gene Therapy|January 9, 2004
Heat shock protein 70 gene therapy combined with hyperthermia using magnetic nanoparticlesAkira Ito, Fumiko Matsuoka, Hiroyuki Honda, et al.
Cancer Gene Therapy|February 7, 2004
Adenoviral-mediated PTEN transgene expression sensitizes Bcl-2-expressing prostate cancer cells to radiationCharles J Rosser, Motoyoshi Tanaka, Louis L Pisters, et al.
Pageof 292